Retrouvez ci-dessous la veille bibliographique élaborée par notre groupe pour le mois de février 2024 !

• Cardiac Troponin in Patients With Light Chain and Transthyretin Cardiac Amyloidosis: JACC: CardioOncology State-of-the-Art Review | Lire l’article JACC
• Clinical and Prognostic Implications of Right Ventricular Uptake on Bone Scintigraphy in Transthyretin Amyloid Cardiomyopathy | Lire l’article Circulation
• Clinical Outcomes Among Immunotherapy-Treated Patients With Primary Cardiac Soft Tissue Sarcomas: A Multicenter Retrospective Study | Lire l’article JACC
• Comparing Anticoagulation Strategies for Venous Thromboembolism Associated With Active Cancer: A Systematic Review and Meta-Analysis | Lire l’article JACC
• Functional Validation of Doxorubicin-Induced Cardiotoxicity-Related Genes | Lire l’article JACC
• Heart Failure Post-Myocardial Infarction Promotes Mammary Tumor Growth Through the NGF-TRKA Pathway | Lire l’article JACC
• Heart Failure Readmission in Patients With ST-Segment Elevation Myocardial Infarction and Active Cancer | Lire l’article JACC
• High-Sensitivity Cardiac Troponin I for Long-Term Cardiovascular Risk Stratification in a Cancer Clinic Population | Lire l’article JACC
• Impact of the ESC Cardio-Oncology Guidelines Biomarker Criteria on Incidence of Cancer Therapy–Related Cardiac Dysfunction | Lire l’article JACC
• Integrated Stress Response Potentiates Ponatinib-Induced Cardiotoxicity | Lire l’article Circulation Research
• Ischaemic heart disease in patients with cancer | Lire l’article European Heart Journal
• Modifiable Cardiometabolic Risk Factors in Survivors of Childhood Cancer: JACC: CardioOncology State-of-the-Art Review | Lire l’article JACC
• Mortality After Major Cardiovascular Events in Survivors of Childhood Cancer | Lire l’article JACC